In many studies, increases in iNKT cell numbers and IFNγ levels were observed but unfortunately, unlike many pre-clinical mouse studies, limited anti-tumor efficacy was seen and ranged from no response up to a partial response (PR). The gene discussed is IFNG; the disease is neoplasm.